Search for Clinical Trial Results

Sponsored By

Keratoconjunctivitis Sicca - 11 Studies Found

Status Study
Terminated Study Name: Omega-3 Fatty Acid Supplements and Dry Eye
Condition: Keratoconjunctivitis Sicca
Date: 2010-09-30
Interventions:
  • Dietary Supplement: Omega-3 Fatty Acid

Completed Study Name: A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye
Condition: Keratoconjunctivitis Sicca
Date: 2015-12-16
Interventions:
  • Drug: 1% Tavilermide Ophthalmic Solution

Completed Study Name: Study of INS365 Ophthalmic Solution in a Controlled Adverse Environment in Patients With Dry Eye
Condition: Keratoconjunctivitis Sicca
Date: 2002-05-18
Interventions: Drug: INS365 Ophthalmic Solution
Completed Study Name: A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye Disease
Condition: Keratoconjunctivitis Sicca
Date: 2016-01-20
Interventions:
  • Drug: 1% Tavilermide Ophthalmic Solution

Completed Study Name: TearLab Core Validation Study to Establish Referent Values for Dry Eye Disease
Condition: Keratoconjunctivitis Sicca
Date: 2009-02-18
Completed Study Name: A Clinical Study to Assess the Safety and Efficacy of an Ophthalmic Solution (SkQ1) in the Treatment of Dry Eye Syndrome
Condition: Keratoconjunctivitis Sicca
Date: 2014-04-17
Interventions:
  • Drug: SkQ1
  • Drug: Placebo SkQ1 (Vehicle)
Withdrawn Study Name: A Study Of Tasocitinib In Dry Eye Subjects
Condition: Keratoconjunctivitis Sicca
Date: 2010-10-20
Interventions:
  • Drug: Tasocitinib 0.005% QD fo
Completed Study Name: Trial of CF101 to Treat Patients With Dry Eye Disease
Condition: Keratoconjunctivitis Sicca
Date: 2010-11-03
Interventions: Drug: CF101 orally q12h Other Name: IB-MECA
Completed Study Name: Dry Eye Assessment and Management: Feasibility Study
Condition:
  • Dry Eye Syndromes
  • Keratoconjunctivitis Si
    Date: 2010-04-09
    Interventions:
    • Drug: Omega-3 EFA Supplement

Completed Study Name: Safety and Efficacy Study of SAR 1118 to Treat Dry Eye Conducted in a Controlled Adverse Environment (CAE)
Condition:
  • Dry Eye
  • Keratoconjunctivitis Sicca
    Date: 2011-08-17
    Interventions:
    • Drug: Lifitegrast Dosage Form:
Next >>>